The development of a short, safe and enantioselective route for the prepara
tion of (R)-aminoglutethimide is described, The process was designed for ec
onomic large-scale manufacture of the bulk drug substance to acceptable qua
lity standards, to allow clinical evaluation of the single enantiomer over
the existing racemate. (R)-Aminoglutethimide was prepared from 1-chloro-4-n
itrobenzene using a six-stage synthetic sequence, via chemoresolution of ke
y intermediate racemic 4-cyano-4-(4-nitrophenyl)hexanoic acid using (-)-cin
chonidine, The process allowed for preparation of several kilograms of the
precursor (R)-nitroglutethimide, to cGMP at pilot-plant scale, along with d
emonstration of the find hydrogenation step to (R)-amino-glutethimide in th
e laboratory, This route avoids the problems of hazardous nitration technol
ogy, and therefore regio-isomer contamination of the product, associated wi
th other procedures. The resolution chemistry described represents an impro
vement on literature procedures, Optimisation of the asymmetric Michael add
ition offers an attractive alternative approach.